Eighty-two percent of 320 clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates from various infection sites collected throughout South Africa were separated into five major globally prevalent clusters by SmaI pulsed-field gel electrophoresis, spa, and SCCmec typing. Only one Panton-Valentine leukocidin-positive isolate was detected. This is the first detailed MRSA epidemiology study for the whole country.
Eighty-two percent of the typeable isolates clustered into five major PFGE types, A (n ϭ 21), D (n ϭ 68), F (n ϭ 20), K (n ϭ 67), and T (n ϭ 77). spa typing of all of the MRSA isolates revealed 31 different spa types, 11 of which were novel. The five most common spa types were t012 (n ϭ 68), t037 (n ϭ 77), t045 (n ϭ 25), t064 (n ϭ 68), and t1257 (n ϭ 31), which made up 84% of the isolates. The spa types were clustered into five spa clonal complexes (spaCC) (Table 1) using the Based Upon Repeat Pattern (BURP) algorithm at a cost setting of Յ5 (14) and excluding spa types with four or fewer repeats. spaCC12 and -64 were the two largest CCs. SCCmec type IV was the most common cassette type (n ϭ 124, 38%), followed by type II (n ϭ 83), type III (n ϭ 80), and type I (n ϭ 33). SCCmec types clustered in congruence with PFGE and spa types (Table 1).
Based on PFGE, spaCC, and SCCmec types, 246/310 isolates (77%) could be grouped into five major clonal types. Two isolates belonging to each of the five clonal types were further subjected to MLST (Table 1) . Five major MRSA clonal lineages were identified: PFGE type A-spa type t045-SCCmecI-ST5 (CC5) (n ϭ 21), PFGE type D-spa type t037-SCCmecIII-ST239 (CC8) (n ϭ 67), PFGE type T-spa type t012-SCCmecII-ST36 (CC30) (n ϭ 76), and PFGE types F (n ϭ 20) and K (n ϭ 61), both having spa type t064-SCCmecIV and belonging to ST612, which is a double-locus variant of ST8 (CC8). Only one PVL-positive MRSA was detected, which belonged to spa type t891, ST22 (CC22), carrying SCCmec type IV. This is the first report on MRSA clonal types circulating in the nine provinces of South Africa. The lineages identified in the present study are major clones that are disseminated worldwide (1). There were two major clones associated with spaCC64-SCCmecIV-CC8: HA-MRSA USA500 (UK-EMRSA-2/-6) and CA-MRSA USA 300 (1). The arginine catabolic mobile element associated with USA300 was not detected by PCR, suggesting that our isolates are likely to be USA500. It was noted that spa types t037 and t012 grouped together in spaCC12 by BURP analysis but clustered independently of each other based on PFGE, SCCmec, and MLST. The presence of these two distinct MRSA clones in spaCC12 can be explained by the recombination of a 557-kb fragment which includes spa from ST30 (CC30) into CC8, resulting in the evolution of ST239 (CC8) (12).
The five major MRSA clones identified in this study were widespread in South Africa (Fig. 1) . However, there appeared to be some geographic associations with specific clones. Type K-spaCC64-SCCmecIV-ST612 was the most widespread clone. Type D-spaCC12-SCCmecIII-ST239 was not detected in the Eastern and Western Cape Provinces. Similarly, type F-spaCC64-SCCmecIV-ST612 was not detected in the Limpopo, Gauteng, and North West Provinces. Only two recent studies provide some insight into the clonal types circulating in KZN (16) and Pretoria, a major city in Gauteng Province (6) . In Durban, KZN, we identified four clones. One of the three clonal types identified by Shittu et al. (16) , namely, t037-ST239-SCCmecIII, was also identified in the present study. In contrast, all our t045-ST5 isolates carried SCCmec type I cassettes, as opposed to the type III cassettes identified by Shittu et al. This suggests two independent SCCmec acquisitions by this clonal lineage within a defined region. Nübel et al. (9) , using single-nucleotide polymorphism analysis, demonstrated that within the MRSA ST5 lineage, there have been multiple independent introductions of SCCmec and that the lineage has been associated with at least six SCCmec types, including types I and III. The t064 clone identified in the present study belonged to a different ST (ST612) but is a single-locus variant of ST1338 and a double-locus variant of ST1173, which were identified by Shittu et al. (16) . Makgotlho et al. (6) published molecular typing data for MRSA isolates from a hospital in Pretoria, but no spa or MLST data were provided; therefore, it is difficult to compare our data. However, they found that 
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SCCmec type II was the predominant cassette type (64%), followed by type III (14%) and type IV (4%). We found three of the five major clones identified this study in Pretoria, which is in agreement with the SCCmec results of Makgotlho et al. (6) . Marais et al. (7) previously published antimicrobial susceptibility data on 247 of the 320 MRSA isolates in this study. The results showed that all were sensitive to vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and fusidic acid, whereas 80% were multidrug resistant (resistant to ␤-lactams and three or more different antimicrobial classes). Ninetythree of the 247 isolates tested by Marais et al. (7) were from blood cultures, and 74 (80%) of them were multidrug resistant. The most common antimicrobial resistance pattern observed was resistance to ␤-lactams, macrolides, lincosamides, and fluoroquinolones (n ϭ 45, 18%) and was mainly associated with spa type t012-SCCmecII-ST36. This antimicrobial resistance pattern is similar to that observed among South African MRSA isolates from 1996 (18) . These four antimicrobial classes are commonly used for the treatment of staphylococcal infections.
The occurrence of indistinguishable and closely related MRSA strains in different hospitals and across different provinces strongly indicates interhospital spread and further demonstrates the clonal nature of MRSA. Shittu et al. (16) found similar results when comparing MRSA isolates from 14 hospitals within the KZN Province. This is the first comprehensive molecular characterization study performed with South African MRSA isolates and demonstrates the presence of a variety of hospital-acquired MRSA clones. These data can serve as a baseline for future MRSA surveillance to study the evolution of MRSA clonal types.
